Identification Module
The Identification Module contains basic identifying information about the clinical trial, including the NCT ID, brief title, official title, acronym, organization study ID information, and organization details. This module provides essential identifiers for the trial.
Identification Module path is as follows:
Study -> Protocol Section -> Identification Module
Identification Module
Ignite Creation Date:
2025-12-25 @ 3:19 AM
Ignite Modification Date:
2025-12-25 @ 3:19 AM
NCT ID:
NCT04822805
Brief Title:
A Study of Anlotinib in the Treatment of Recurrent High-grade Glioma
Official Title:
Anlotinib in the Treatment of Recurrent High-grade Gliomaļ¼ an Open-label Single-arm, Phase 2 Trials
Study:
NCT04822805
Protocol Section:
NCT04822805